The Poultry Drug, Roxarsone, credits to be an ancient treatment since 1940 to protect chickens from a parasitic disease and to help them in weight gain. However, on Wednesday, officials have announced that the treatment is pulled out of the market as federal scientists observed a potentially carcinogenic form of arsenic in the livers of animals treated with the substance.
The Food and Drug and Administration (FDA) had notified that during a study around 100 broiler chickens were observed with a form of arsenic known as inorganic arsenic, which is a known carcinogen, at increased level in the livers of birds, treated with the drug compared to those that were not.
On the other hand, the public health and industry experts claimed that the acknowledged levels of arsenic were very low to caste a health problem. Further, they stressed that eating poultry animals treated with the drug "does not pose a health risk”.
The National Chicken Council, an industry group, had released a statement and claimed that chicken remains safe to eat. “Chicken companies will continue to safeguard chicken flocks because healthy flocks are needed to produce healthful food for people.
0 comments:
Post a Comment